Variability of protein and phosphoprotein levels in clinical tissue specimens during the preanalytical phase.

The quality of human tissue specimens can have a significant impact on analytical data sets for biomarker research. The aim of this study was to characterize fluctuations of protein and phosphoprotein levels in human tissue samples during the preanalytical phase. Eleven intestine and 17 liver specimens were surgically resected, aliquoted, and either snap-frozen or fixed in formalin immediately or exposed to different ischemic conditions before preservation. Protein levels in the resultant samples were investigated by reverse phase protein array, Western blot analysis, and liquid chromatography-tandem mass spectrometry. Our data revealed that the degree of sensitivity of proteins and phosphoproteins to delayed preservation varied between different patients and tissue types. For example, up-regulation of phospho-p42/44 MAPK in intestine samples was seen in some patients but not in others. General trends toward up- or down-regulation of most proteins were not evident due to pronounced interpatient variability but signal intensities of only a few proteins, such as cytokeratin 18, were altered from baseline in postresection samples. In contrast, glyceraldehyde 3-phosphate dehydrogenase was found to be stable during periods of cold ischemia. Our study represents a proper approach for studying potential protein fluctuations in tissue specimens for future biomarker development programs.

[1]  S. Jewell,et al.  Analysis of the molecular quality of human tissues: an experience from the Cooperative Human Tissue Network. , 2002, American journal of clinical pathology.

[2]  H. Juhl,et al.  Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision. , 2004, BioTechniques.

[3]  G. Poste.  Bring on the biomarkers , 2011, Nature.

[4]  K. Creek,et al.  RNA degradation in human breast tissue after surgical removal: a time-course study. , 2004, Experimental and molecular pathology.

[5]  Friedrich Lottspeich,et al.  Quantitative analysis of 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin‐induced proteome alterations in 5L rat hepatoma cells using isotope‐coded protein labels , 2006, Proteomics.

[6]  H. Höfler,et al.  Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients , 2010, Virchows Archiv.

[7]  H. Juhl.  Preanalytical aspects: A neglected issue , 2010, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[8]  C. Buske,et al.  Label-free protein profiling of formalin-fixed paraffin-embedded (FFPE) heart tissue reveals immediate mitochondrial impairment after ionising radiation. , 2012, Journal of proteomics.

[9]  F. Pontén,et al.  Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens , 2006, Laboratory Investigation.

[10]  K. Coombes,et al.  A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers , 2010, Clinical Proteomics.

[11]  E. Petricoin,et al.  A Portrait of Tissue Phosphoprotein Stability in the Clinical Tissue Procurement Process* , 2008, Molecular & Cellular Proteomics.

[12]  K. Hansen,et al.  Sequencing technology does not eliminate biological variability , 2011, Nature Biotechnology.

[13]  Z. Szallasi,et al.  Targeting chromosomal instability and tumour heterogeneity in HER2‐positive breast cancer , 2010, Journal of cellular biochemistry.

[14]  C. Gulmann,et al.  Array‐based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer , 2006, The Journal of pathology.

[15]  H. Sarioglu,et al.  Analysis of 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced Proteome Changes in 5L Rat Hepatoma Cells Reveals Novel Targets of Dioxin Action Including the Mitochondrial Apoptosis Regulator VDAC2*S , 2008, Molecular & Cellular Proteomics.

[16]  P. Selby,et al.  Mining the archival formalin-fixed paraffin-embedded tissue proteome: opportunities and challenges. , 2008, Molecular bioSystems.

[17]  P. Riegman,et al.  A new technology for stabilization of biomolecules in tissues for combined histological and molecular analyses. , 2012, The Journal of molecular diagnostics : JMD.

[18]  D. Rimm,et al.  Quantitative Assessment Shows Loss of Antigenic Epitopes as a Function of Pre-analytic Variables , 2011, Laboratory Investigation.

[19]  Kurt Zatloukal,et al.  Proteomic analysis of PAXgene-fixed tissues. , 2010, Journal of proteome research.

[20]  K. Becker,et al.  Successful Protein Extraction from Over-Fixed and Long-Term Stored Formalin-Fixed Tissues , 2011, PloS one.

[21]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[22]  Daniela Berg,et al.  Molecular profiling of signalling pathways in formalin-fixed and paraffin-embedded cancer tissues. , 2010, European journal of cancer.

[23]  T. Holzer,et al.  Ischemic time impacts biological integrity of phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK signaling networks. , 2011, Anticancer research.

[24]  R. Langer,et al.  Protein Microarray-based Comparison of HER2, Estrogen Receptor, and Progesterone Receptor Status in Core Biopsies and Surgical Specimens From FFPE Breast Cancer Tissues , 2011, Applied immunohistochemistry & molecular morphology : AIMM.

[25]  E. Petricoin,et al.  Tissue is alive: New technologies are needed to address the problems of protein biomarker pre‐analytical variability , 2009, Proteomics. Clinical applications.

[26]  A. L. Bosch,et al.  TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. , 2006, European journal of cancer.

[27]  K. Becker,et al.  “Liquid Morphology”: Immunochemical Analysis of Proteins Extracted From Formalin-fixed Paraffin-embedded Tissues Combining Proteomics With Immunohistochemistry , 2011, Applied immunohistochemistry & molecular morphology : AIMM.

[28]  Kurt Zatloukal,et al.  Histological Assessment of PAXgene Tissue Fixation and Stabilization Reagents , 2011, PloS one.

[29]  Virginia Espina,et al.  Reverse phase protein microarrays advance to use in clinical trials , 2010, Molecular oncology.

[30]  M. Dowsett,et al.  Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer , 2010, Breast Cancer Research.

[31]  J. Nährig,et al.  Quantitative protein analysis from formalin‐fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis , 2007, The Journal of pathology.

[32]  J. Chiu,et al.  Cross‐linked Cytokeratin Polypeptides in Liver and Hepatoma Cells: Possible Association with the Process of Cell Degeneration and Death , 1993, Hepatology.

[33]  M. Mann,et al.  Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. , 2010, Journal of proteome research.